Stacey A. Rutherford

Potently neutralizing and protective human monoclonal antibodies against the measles fusion protein trimer.

Measles remains a significant source of morbidity and mortality globally. There are currently no licensed treatments for patients at high risk of severe disease. There is limited knowledge about the human antibody response to a measles infection or vaccination or the structural determinants of antibody-mediated neutral...